Cargando…
Gain of toxic Apolipoprotein E4 effects in Human iPSC-Derived Neurons Is Ameliorated by a Small-Molecule Structure Corrector
Efforts to develop drugs for Alzheimer’s disease (AD) have shown promise in animal studies, only to fail in human trials, suggesting a pressing need to study AD in human model systems. Using human neurons derived from induced pluripotent stem cells carrying the major genetic risk factor apolipoprote...
Autores principales: | Wang, Chengzhong, Najm, Ramsey, Xu, Qin, Jeong, Dah-eun, Walker, David, Balestra, Maureen E., Yoon, Seo Yeon, Yuan, Heidi, Li, Gang, Miller, Zachary A., Miller, Bruce L., Malloy, Mary J., Huang, Yadong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5948154/ https://www.ncbi.nlm.nih.gov/pubmed/29632371 http://dx.doi.org/10.1038/s41591-018-0004-z |
Ejemplares similares
-
Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer’s disease
por: Najm, Ramsey, et al.
Publicado: (2019) -
A human iPSC-derived hepatocyte screen identifies compounds that inhibit production of Apolipoprotein B
por: Liu, Jui-Tung, et al.
Publicado: (2023) -
Apolipoprotein E regulates lipid metabolism and α-synuclein pathology in human iPSC-derived cerebral organoids
por: Zhao, Jing, et al.
Publicado: (2021) -
Banking on iPSC- Is it Doable and is it Worthwhile
por: Solomon, Susan, et al.
Publicado: (2014) -
Roadblocks in the Path of iPSC to the Clinic
por: Garreta, Elena, et al.
Publicado: (2018)